Neurology

A trio of experts from Sinaptica Therapeutics talked about recent findings presented at CTAD 2024…

The director of the myasthenia gravis clinic at Yale University discussed the therapeutic potential of…

The NDA includes data from a global placebo-controlled, 72-week study as well as findings from…

The director of the Muscular Dystrophy Clinic at UCSF Benioff Children’s Hospital provided insight on…

The multidisciplinary, 1-day scientific forum will be held May 15, 2025, in Charleston, South Carolina,…

Using a Brain-Chip model, investigators demonstrated that pepinemab can inhibit or reverse damage from toxic…

A feature on NeurologyLive®, IJMSC Insights offers a closer look at the latest research and…

Clinicians discussed the complexities of diagnosing Long COVID, emphasizing the need for improved biomarkers and…

Over a 48-week treatment period, once daily blarcamesine slowed clinical decline in patients with early-stage…

The data scientist at Roche and mother of a child living with Lennox-Gastaut syndrome, provided…